Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

• Lingfeng Yang,
• Kristy Iglay,
• Tracey Weiss,
• Swapnil Rajpathak,
• Richard D Carr,
• Sampriti Pal,
• Baanie Sawhney,
• Robert Boggs

Affiliations

Lingfeng Yang

Merck & Co., Inc, Kenilworth, New Jersey, USA

Kristy Iglay

Merck & Co., Inc, Kenilworth, New Jersey, USA

Tracey Weiss

Merck & Co., Inc, Kenilworth, New Jersey, USA

Swapnil Rajpathak

Merck & Co., Inc, Kenilworth, New Jersey, USA

Richard D Carr

Merck & Co., Inc, Kenilworth, New Jersey, USA

Sampriti Pal

Complete HEOR Solutions, North Wales, Pennsylvania, USA

Baanie Sawhney

Complete HEOR Solutions, North Wales, Pennsylvania, USA

Robert Boggs

Merck & Co., Inc, Kenilworth, New Jersey, USA